Bortezomib enhances the efficacy of fulvestrant by amplifying the aggregation of the estrogen receptor, which leads to a proapoptotic unfolded protein response.

Source:http://linkedlifedata.com/resource/pubmed/id/21292820

Clin. Cancer Res. 2011 Apr 15 17 8 2292-300

Download in:

View as

General Info

PMID
21292820